In the Media

Under the direction of CEO Noubar Afeyan PhD '87, a member of the MIT Corporation, Flagship Pioneering is using its resources to back life sciences companies, seeking to vertically integrate the processes of scientific discovery, reports Scott Kirsner for The Boston Globe. “Afeyan’s latest vision involves artificial intelligence and how it will change the way science and drug development are done,” he writes. “Afeyan says that AI could eventually become a tool that does much of the work of scientific discovery.”